Butyrate, a fatty acid made by gut bacteria from fiber, is sold as a supplement for gut and metabolic health. The most consistent benefits are eased irritable bowel symptoms, greater weight loss with dieting and better antibiotic treatment of a common stomach infection. Side effects at usual doses are mostly mild digestive upset, but one study found blood pressure rose in people with high blood pressure. Healthy-aging benefits remain unproven. (Full Review)

Protocol

Sodium butyrate (research protocol)

300 mg–4 g/day

Metabolic and bowel studies typically 1.5–4 g/day in divided doses, often microencapsulated or enteric-coated

Calcium and calcium-magnesium butyrate

500–1,000 mg/day

Common supplement forms; hypertension and sodium restriction favor non-sodium forms

Single vs split dosing

Usually 2–3 split doses above 1 g/day

No trial compared timing; most dosed with meals, mainly for tolerability; butyrate clears from blood within minutes

Time to effect

Bowel symptoms

4–8 weeks

Irritable bowel symptom relief measured over 8 weeks

Weight and waist

12 weeks–6 months

Alongside diet; 12 weeks in adults, 6 months in children

Sleep quality

12 weeks

In active ulcerative colitis; untested without bowel inflammation

Benefits

High: Irritable bowel syndrome symptom relief; body weight and waist reduction alongside diet; higher H. pylori eradication with fewer side effects

Medium: Better sleep quality; fewer episodes of inflamed colon pouches

Low: Crohn's disease and ulcerative colitis activity; blood sugar and insulin sensitivity; triglyceride reduction; lower systemic inflammation; muscle strength and physical function in older adults; liver fat reduction; mood and depressive symptoms; colorectal cancer prevention

Speculative: Gut barrier repair; healthy aging and lifespan; brain health and cognition

Contraindications

Untreated or uncontrolled hypertension (≥140/90 mmHg) without home blood pressure monitoring

Strict sodium restriction (sodium butyrate form): heart failure NYHA Class III–IV or chronic kidney disease stage 4–5 (eGFR below 30 mL/min/1.73 m²)

Pregnancy and breastfeeding

Lynch syndrome or known mismatch-repair deficiency

Histone deacetylase inhibitor cancer therapy

Key Interactions

Antihypertensive drugs (amlodipine, lisinopril, losartan): caution

Diuretics (furosemide, hydrochlorothiazide, spironolactone): monitor

HDAC inhibitor drugs (valproic acid): caution

Mesalamine (Asacol, Lialda, Pentasa): potentially additive benefit

Antibiotics (amoxicillin-clavulanate, ciprofloxacin, clindamycin): monitor

Sodium-containing over-the-counter antacids (sodium bicarbonate, Alka-Seltzer): monitor

Prebiotics (inulin, resistant starch, psyllium): additive

Butyrate-producing probiotics (Clostridium butyricum, multi-strain butyrate blends): additive

Calcium and magnesium supplements (calcium carbonate, magnesium citrate): additive mineral intake

Ketogenic diets (very low-carbohydrate, high-fat eating): reduce the body's own butyrate production

Risk & Side Effects

Medium: Gastrointestinal upset and unpleasant odor

Low: Blood pressure increase; cholesterol rise; liver enzyme elevation

Speculative: Sodium load; tumor promotion in mismatch-repair deficiency

Monitoring

Marker	Target	Why
Blood pressure	<120/80 mmHg	Detect butyrate-related rise
Fasting glucose	75–90 mg/dL	Glycemic response
Fasting insulin	2–6 µIU/mL	Insulin sensitivity
HbA1c	4.8–5.3%	Three-month glucose average
LDL cholesterol	<100 mg/dL	Detect lipid rise
Triglycerides	<100 mg/dL	Metabolic response
hs-CRP	<1.0 mg/L	Systemic inflammation
Fecal calprotectin	<50 µg/g	Gut inflammation
Serum sodium and eGFR	Sodium 138–142 mmol/L; eGFR >90 mL/min/1.73 m²	Sodium load and kidney function
ALT	10–25 U/L	Liver safety
Stool butyrate (optional)	No established target; track change from own baseline	Confirms colonic exposure
Body weight and waist circumference	Change from own baseline	Metabolic goal response

Cadence: Baseline before starting; blood pressure weekly for the first 4–8 weeks, then monthly; labs at 8–12 weeks, then every 6–12 months while supplementation continues

Qualitative Assessment

Bowel regularity and stool form (Bristol Stool Form Scale)
Abdominal pain, bloating and urgency
Sleep quality and daytime energy
Appetite and satiety between meals
Tolerability of odor and taste

Butyrate for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment